Jarislowsky, Fraser Ltd’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-7,620
Closed -$738K 218
2018
Q3
$738K Sell
7,620
-308
-4% -$26.3K ﹤0.01% 168
2018
Q2
$612K Buy
7,928
+146
+2% +$11K ﹤0.01% 172
2018
Q1
$537K Hold
7,782
﹤0.01% 180
2017
Q4
$580K Buy
7,782
+390
+5% +$24.9K ﹤0.01% 182
2017
Q3
$468K Hold
7,392
﹤0.01% 180
2017
Q2
$471K Sell
7,392
-400
-5% -$25.1K ﹤0.01% 170
2017
Q1
$513K Sell
7,792
-72
-0.9% -$4.95K ﹤0.01% 167
2016
Q4
$540K Buy
+7,864
New +$564K ﹤0.01% 166

Other funds holding ESRX

Jarislowsky, Fraser Ltd's ESRX Position: Q4 2018 in Review

Jarislowsky, Fraser Ltd sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 7,620 shares — an estimated $738K sold.

Jarislowsky, Fraser Ltd first reported a position in ESRX in Q4 2016 and held it in 8 quarters. The position peaked at $738K in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Jarislowsky, Fraser Ltd reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Jarislowsky, Fraser Ltd sold 7,620 Express Scripts Holding Company shares in Q4 2018, an estimated $738K.
  • Jarislowsky, Fraser Ltd first reported a position in Express Scripts Holding Company in Q4 2016 and held it in 8 quarters.
  • Jarislowsky, Fraser Ltd's Express Scripts Holding Company position peaked at $738K in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Jarislowsky, Fraser Ltd's 13F filing for Q4 2018, filed 1 Feb 2019.